Public Citizen Accuses Pfizer of Building ‘Paxlovid Patent Wall,’ Pfizer Pushes Back Post author:PacConAdmin Post published:February 18, 2022 Post category:Drug Industry Daily The advocacy group Public Citizen is accusing Pfizer of building a “Paxlovid patent wall.” Source: Drug Industry Daily You Might Also Like FDA Delays Intended-Use Rule Implementation Amid Industry Outcry January 16, 2018 Pew Finds State Oversight of Compounders Improved, But Some Lack Inspection Resources February 27, 2018 Dr. Reddy’s Hit With 483 for Supplier Quality Agreements, CAPA Issues March 30, 2018
Pew Finds State Oversight of Compounders Improved, But Some Lack Inspection Resources February 27, 2018